However, they displayed slightly less CD3+, CD4+, and CD8+ T‐cell in the brain compared to GIFT‐7TVax mice 1 week post‐tumor implantation, although a statistically significant difference was not reached (LTS vs GIFT‐7TVax: CD3+: 24.5% Vs 32.3% p = NS; CD4+: 9.1% Vs 1.6% p = NS; CD8+: 8.1% Vs 5.7% p = NS) (Figure 4b). The gene discussed is CD4; the disease is neoplasm.